University of Michigan/Kellogg Eye Center
Ann Arbor, Michigan 48105
We've found
9 trials
at this facility
Geographic Atrophy Clinical Trial
Updated: 12/31/1969
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cerebrotendinous Xanthomatosis (CTX) Clinical Trial
Updated: 12/31/1969
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
AMD Clinical Trial
Updated: 12/31/1969
Post-Approval Study of the Implantable Miniature Telescope
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Macular Telangiectasia Clinical Trial
Updated: 12/31/1969
Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ophthalmology, Reproductive Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Updated: 4/25/2018
Telescope Exchange Study
Status: Enrolling
Updated: 4/25/2018
Click here to add this to my saved trials
Retinitis Pigmentosa Clinical Trial
Updated: 12/31/1969
New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Macular Degeneration Clinical Trial
Updated: 1/7/2016
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling,
Phase
I, II
Updated: 1/7/2016
Click here to add this to my saved trials
Macular Telangiectasia Type 2 Clinical Trial
Updated: 12/31/1969
A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials